These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy. Kenner JR J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847 [TBL] [Abstract][Full Text] [Related]
6. Global 3-dimensional approach to natural rejuvenation: recommendations for perioral, nose, and ear rejuvenation. Gassia V; Raspaldo H; Niforos FR; Michaud T J Cosmet Dermatol; 2013 Jun; 12(2):123-36. PubMed ID: 23725306 [TBL] [Abstract][Full Text] [Related]
7. What does the future hold for botulinum neuromodulators in facial aesthetics? Sattler G J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):394-5. PubMed ID: 21492251 [No Abstract] [Full Text] [Related]
8. Fillers and the "three curves of youth". Fitzgerald R J Drugs Dermatol; 2012 Aug; 11(8):s9-11; discussion s11. PubMed ID: 22859223 [TBL] [Abstract][Full Text] [Related]
19. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Carruthers A; Carruthers J; Monheit GD; Davis PG; Tardie G Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044 [TBL] [Abstract][Full Text] [Related]
20. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Carruthers J; Carruthers A; Monheit GD; Davis PG Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]